OPEN END TURBO LONG - MERCK & CO. | Real-time Bid/Ask 14:00:16 03/06/2024 BST | ||
| 3.46 EUR / 3.5 EUR | +1.16% |
|
| 1 month | -12.47% | ||
| 3 months | -9.47% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
| Date | Price | Change |
|---|---|---|
| 03/06/24 | 3.4 | -1.16% |
| 31/05/24 | 3.44 | +2.99% |
| 30/05/24 | 3.34 | -4.30% |
| 29/05/24 | 3.49 | +0.58% |
| 28/05/24 | 3.47 | -8.20% |
Delayed Quote Börse Stuttgart
Last update June 03, 2024 at 01:26 pm
More quotesStatic data
| Product type | Warrant Knock-Out senza Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | Morgan Stanley |
| WKN | MD3643 |
| ISIN | DE000MD36430 |
| Date issued | 05/04/2022 |
| Strike | 88.41 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.62 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 4.26 € |
|---|---|
| Lowest since issue | 0.59 € |
| Spread | 0.1 € |
| Spread % | 2.86% |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
125.5
USD
Average target price
141.9
USD
Spread / Average Target
+13.01%
- Stock Market
- Certificates
- Certificat
